Politician Profile Page
Health
Department of Health on its 2nd and 3rd quarterly reports; DPME on Health Department performance outcomes
18 Mar 2015
The Department of Health (DoH) briefed the Committee on its performance in Quarters 2 and 3, followed by an evaluation report presented by the Department of Performance Monitoring and Evaluation (DPME), explaining how it categorised performance, and that it was done to assess how the sector as a whole was ...
Rural Development and Land Reform
Ingonyama Trust Board 3rd Quarter 2014/15 Performance Report
11 Mar 2015
The Committee was briefed by the Ingonyama Trust Board (ITB) on its third quarter 2014/15 performance and financial report. Apologies were received from the Minister and Deputy Minister. At the outset, Members expressed their dismay that the ITB was reporting from a document that contained different figures to the one ...
Health
Traditional and Natural Health Alliance submission on Medicines and Related Substances Amendment Bill: Department & legal advisors response
4 Mar 2015
The Department of Health and Parliamentary Legal Advisors presented their responses to a further submission, heard in the previous week, from the Traditional and Natural Health Alliance (TNHA). The Department of Health (DoH) clarified the definition of traditional medicine, and how the regulation of the products, practice and profession of ...
Health
Medicines and Related Substances Amendment Bill [B6-2014]: deliberations
18 Feb 2015
The Committee firstly discussed a request from the Traditional and Natural Health Alliance (TNHA) to make another presentation on the Medicines and Controlled Substances Amendment Bill, since it had been apparent from the last presentation that this body had not understood the nature of the public hearings and had been ...
Health
Medicines and Related Substances Amendment Bill: Response by Department of Health to submissions made during public hearings
19 Nov 2014
The Committee met to hear the comments of the Department of Health (DoH) on the public hearings on the Medicines and Related Substances Amendment Bill that took place recently.
The Amendment Bill addressed which types of medicines, in vitro diagnostics (IVDs) and medical devices were regulated, and where these products ...
Ethics and Members' Interest
Joint Committee's Annual Report; Consideration of a complaint by Hon HB Holomisa (complaint handled in closed session)
12 Nov 2014
The Committee meeting started late, as insufficient Members were present to achieve a quorum. A DA Member noted her dissatisfaction with the time wasted, and suggested that in future, should insufficient numbers be present within 15 minutes of the scheduled time, the meeting should be adjourned. However, an ANC Member ...
Health
Mr and Mrs Lowe on organ donation in South Africa
12 Nov 2014
The Committee met to hear a briefing by the parents of Jenna Lowe, who has been diagnosed with a rare disease called Pulmonary Arterial Hypertension (PAH) and is currently awaiting a bilateral lung transplant, on creating awareness for organ donation in South Africa.
Mr Stuart Lowe and Mrs Gabi Lowe ...
Health
Medicines and Related Substances Amendment Bill [B6 - 2014]: Public hearings
5 Nov 2014
The Committee met briefly to hear public submissions on the Medicines and Related Substances Amendment Bill (the Bill). Most of the submissions related to what was included in the Bill and definitions, and gave clarity on possible gaps.
The Regulatory Discussion Group (RDG) said its concerns with the Bill were ...
Health
Medicines & Related Substances Amendment Bill [B6-2014]: public hearings day 2
31 Oct 2014
The Portfolio Committee met to continue its public hearings on the Medicines and Related Substances Amendment Bill.
The Pharmaceutical Society of South Africa (PSSA) said they understood and supported the Bill but they had some concerns. PSSA supported the replacement of "products" with "medicines" when it was appropriate. Section 6 ...
Health
Medicines & Related Substances Amendment Bill [B6-2014]: public hearings day 1
29 Oct 2014
The Portfolio Committee met to conduct public hearings on the Medicines and Related Substances Amendment Bill. During the meeting, the Committee received briefings from seven institutions.
Roche Diagnostic (RD) is a world leader in the management of diabetes which imported and exported IVDs and specialised in marketing, sales, installation and ...